{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:27:07Z","timestamp":1785148027694,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ccm.2019.05.012","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T10:13:06Z","timestamp":1564567986000},"page":"573-582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Update on the Management of Respiratory Manifestations of the Antineutrophil Cytoplasmic Antibodies-Associated Vasculitides"],"prefix":"10.1016","volume":"40","author":[{"given":"Gwen E.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Specks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ccm.2019.05.012_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised international Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.ccm.2019.05.012_bib2","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A","article-title":"Antineutrophil cytoplasmic antibodies","volume":"41","author":"Hoffman","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.012_bib3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9343(03)00359-0","article-title":"Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists","volume":"115","author":"Keogh","year":"2003","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.ccm.2019.05.012_bib4","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/art.21250","article-title":"Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome","volume":"52","author":"Sinico","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.012_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"36","key":"10.1016\/j.ccm.2019.05.012_bib6","first-page":"195","article-title":"Wegener's granulomatosis in the 1990s\u2013a pulmonary pathologist's perspective","author":"Colby","year":"1993","journal-title":"Monogr Pathol"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.012_bib7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00000478-199104000-00001","article-title":"Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients","volume":"15","author":"Travis","year":"1991","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.012_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/1054-8807(94)90032-9","article-title":"Common and uncommon manifestations of Wegener's granulomatosis","volume":"3","author":"Travis","year":"1994","journal-title":"Cardiovasc Pathol"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.012_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1148\/rg.321115060","article-title":"Common and uncommon manifestations of Wegener granulomatosis at chest CT: radiologic-pathologic correlation","volume":"32","author":"Martinez","year":"2012","journal-title":"Radiographics"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.012_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3109\/00365548609021666","article-title":"Nocardiosis mimicking Wegener's granulomatosis","volume":"18","author":"Gibb","year":"1986","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.012_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4103\/0970-2113.184873","article-title":"Clinical spectrum and outcome of pulmonary nocardiosis: 5-year experience","volume":"33","author":"Singh","year":"2016","journal-title":"Lung India"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.012_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2214\/ajr.142.1.79","article-title":"Chest radiograph in lymphomatoid granulomatosis: comparison with Wegener granulomatosis","volume":"142","author":"Wechsler","year":"1984","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.012_bib13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/PPO.0b013e31826c5e19","article-title":"Lymphomatoid granulomatosis","volume":"18","author":"Roschewski","year":"2012","journal-title":"Cancer J"},{"issue":"2 Pt 1","key":"10.1016\/j.ccm.2019.05.012_bib14","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1164\/ajrccm.151.2.7842215","article-title":"Tracheobronchial involvement in Wegener's granulomatosis","volume":"151","author":"Daum","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.ccm.2019.05.012_bib15","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ccm.2019.05.012_bib16","first-page":"2017","article-title":"Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations","volume":"35","author":"Seo","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.012_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.012_bib18","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/annrheumdis-2015-208073","article-title":"Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type","volume":"75","author":"Unizony","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.012_bib19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.rdc.2007.09.004","article-title":"Airway involvement in Wegener's granulomatosis","volume":"33","author":"Polychronopoulos","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.012_bib20","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.semarthrit.2018.05.005","article-title":"Frequency, treatment, evolution, and factors associated with the presence of tracheobronchial stenoses in granulomatosis with polyangiitis. Retrospective analysis of a case series from a single respiratory referral center","volume":"48","author":"Marroquin-Fabian","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.012_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.012_bib22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ccm.2019.05.012_bib23","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1002\/art.34562","article-title":"Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis","volume":"64","author":"Lionaki","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.012_bib24","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1378\/chest.08-1180","article-title":"Relapsing polychondritis and airway involvement","volume":"135","author":"Ernst","year":"2009","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.012_bib25","doi-asserted-by":"crossref","first-page":"470","DOI":"10.5858\/arpa.2016-0188-RS","article-title":"Large and small airway disease related to inflammatory bowel disease","volume":"141","author":"Chiu","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.012_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09031936.00.15100500","article-title":"The lung in inflammatory bowel disease","volume":"15","author":"Camus","year":"2000","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.012_bib27","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1378\/chest.08-2569","article-title":"Airway involvement in sarcoidosis","volume":"136","author":"Polychronopoulos","year":"2009","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.012_bib28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1378\/chest.121.1.242","article-title":"CT virtual bronchoscopy of the central airways in patients with Wegener's granulomatosis","volume":"121","author":"Summers","year":"2002","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.012_bib29","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/archinte.1996.00440040118013","article-title":"The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition","volume":"156","author":"Niles","year":"1996","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.012_bib30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.012_bib31","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/art.39562","article-title":"Diffuse alveolar hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: predictors of respiratory failure and clinical outcomes","volume":"68","author":"Cartin-Ceba","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.012_bib32","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1378\/chest.08-2084","article-title":"Diffuse alveolar hemorrhage","volume":"137","author":"Lara","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.012_bib33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0002-9343(89)80606-0","article-title":"Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients","volume":"87","author":"Robbins","year":"1989","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.012_bib34","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1183\/09031936.00119108","article-title":"Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage","volume":"33","author":"Maldonado","year":"2009","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.012_bib35","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1378\/chest.120.6.2013","article-title":"Time course of hemosiderin production by alveolar macrophages in a murine model","volume":"120","author":"Epstein","year":"2001","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.ccm.2019.05.012_bib36","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1681\/ASN.2010050477","article-title":"Histopathologic classification of ANCA-associated glomerulonephritis","volume":"21","author":"Berden","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ccm.2019.05.012_bib37","article-title":"Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort","author":"Berti","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl_1","key":"10.1016\/j.ccm.2019.05.012_bib38","doi-asserted-by":"crossref","first-page":"i139","DOI":"10.1093\/ndt\/gfw299","article-title":"Complement activation in pauci-immune necrotizing and crescentic glomerulonephritis: results of a proteomic analysis","volume":"32","author":"Sethi","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.012_bib39","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1183\/09031936.00075309","article-title":"Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality","volume":"35","author":"de Prost","year":"2010","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.012_bib40","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00005792-200007000-00003","article-title":"Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies \u201cOrphelines\u201d Pulmonaires (GERM\"O\"P)","volume":"79","author":"Lauque","year":"2000","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.012_bib41","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1053\/j.ajkd.2003.08.015","article-title":"Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis","volume":"42","author":"Klemmer","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"suppl 10","key":"10.1016\/j.ccm.2019.05.012_bib42","article-title":"The effects of plasma exchange and reduced-dose glucocorticoids during remission-induction for treatment of severe ANCA-associated vasculitis","volume":"70","author":"Walsh","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2019.05.012_bib43","first-page":"51","article-title":"Interstitial lung disease with ANCA-associated vasculitis","volume":"9","author":"Katsumata","year":"2015","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"issue":"7","key":"10.1016\/j.ccm.2019.05.012_bib44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.autrev.2017.05.008","article-title":"Interstitial lung disease in ANCA vasculitis","volume":"16","author":"Alba","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.012_bib45","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1055\/s-0038-1669914","article-title":"Antineutrophil cytoplasmic antibody-associated lung fibrosis","volume":"39","author":"Borie","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.012_bib46","doi-asserted-by":"crossref","first-page":"e000058","DOI":"10.1136\/bmjresp-2014-000058","article-title":"Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis","volume":"2","author":"Kagiyama","year":"2015","journal-title":"BMJ Open Respir Res"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.012_bib47","doi-asserted-by":"crossref","first-page":"e0199659","DOI":"10.1371\/journal.pone.0199659","article-title":"Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias","volume":"13","author":"Hozumi","year":"2018","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.ccm.2019.05.012_bib48","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Idiopathic Pulmonary Fibrosis Clinical Research Network","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.ccm.2019.05.012_bib49","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ccm.2019.05.012_bib50","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejim.2015.04.022","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management","volume":"26","author":"Groh","year":"2015","journal-title":"Eur J Intern Med"},{"issue":"9","key":"10.1016\/j.ccm.2019.05.012_bib51","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/ndt\/gfq852","article-title":"Rituximab for the treatment of Churg-Strauss syndrome with renal involvement","volume":"26","author":"Cartin-Ceba","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.012_bib52","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/annrheumdis-2014-206095","article-title":"Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"75","author":"Mohammad","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.012_bib53","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2010.03.028","article-title":"Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome","volume":"125","author":"Kim","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.012_bib54","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.jaci.2018.11.041","article-title":"Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis","volume":"143","author":"Steinfeld","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523119300401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523119300401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:58:19Z","timestamp":1759453099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523119300401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0272523119300401"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2019.05.012","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on the Management of Respiratory Manifestations of the Antineutrophil Cytoplasmic Antibodies-Associated Vasculitides","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2019.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}